Mylan’s Generic EpiPen Cuts Patient Cost in Half

What's Hot

How to Cut the Cable TV Cord in 2017Family

8 Major Freebies and Discounts You Get With Amazon PrimeSave

8 Creative Ways to Clear ClutterAround The House

Study: People Who Curse Are More HonestFamily

This Free Software Brings Old Laptops Back to LifeMore

Pay $2 and Get Unlimited Wendy’s Frosty Treats in 2017Family

The 3 Golden Rules of Lending to Friends and FamilyBorrow

6 Reasons Why Savers Are Sexier Than SpendersCredit & Debt

Resolutions 2017: Save More Money Using 5 Simple TricksCredit & Debt

Porta-Potties for Presidential Inauguration Cause a StinkFamily

Protecting Trump Will Cost Taxpayers $35 MillionFamily

7 New Year’s Resolutions to Make With Your KidsFamily

5 New Year’s Resolutions That Will Pay Off 10 Years From NowCollege

10 Tasty Alcohol-Free Drinks That Adults Will LoveFamily

10 Simple Money Moves to Make Before the New YearFamily

Could Your Pet Benefit From Marijuana-Laced Treats?Family

The drug company spent much of the year facing a torrent of criticism over the high price of its life-saving allergy medication.

Here is some good news for those who suffer from life-threatening allergies: Drugmaker Mylan is launching a half-priced generic version of its popular, — but prohibitively expensive — EpiPen.

Mylan made headlines this fall, when it was reported the company had increased the price of the EpiPen — a medical device that can stop a potentially deadly reaction to a bee sting or some types of consumed food — by a jaw-dropping 400 percent between 2008 and 2016. The price jump triggered a federal probe and widespread criticism from consumers.

Mylan purchased EpiPen from another drugmaker in 2007, when the allergy devices had a wholesale price of roughly $57 each and sold in pharmacies for about $100.

The EpiPens contain about $1 worth of epinephrine. The price for a two-pack of EpiPens today tops $600. According to the Associated Press, Mylan says it will charge $300 for a generic two-pack of the life-saving epinephrine devices.

Although it’s not known how much consumers will actually save by purchasing the generic pens — rather than the brand name EpiPens — the generic devices are a clear boon to Mylan. The AP explains:

The potential [consumer] cost savings will depend in part on a patient’s insurance coverage and qualifications for discount and assistance programs that the drugmaker also provides.
For Mylan, the benefit from its long-promised generic is more certain: It is expected to generate millions of dollars in revenue while also protecting the drugmaker’s market share against competition.

The generic EpiPens should hit pharmacy store shelves this week, CBS reports.

For another alternative to EpiPens, check out “$30 ‘EpiPencil’ Is DIY Alternative to EpiPen.”

What do you think about Mylan’s generic alternative to the EpiPen? Sound off below or on Facebook.

Stacy Johnson

It's not the usual blah, blah, blah

I know... every site you visit wants you to subscribe to their newsletter. But our news and advice is actually worth reading! For 25 years, I've been making people richer without making their eyes glaze over. You'll be glad you did. I guarantee it!


Read Next: 8 Ways to Get Your FICO Score for Free

Check Out Our Hottest Deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 1,832 more deals!